News Gilead donates Truvada to HIV trial patients PROUD trial patients can continue treatment for six months.
News Charity raises funds for legal fight over HIV drug National AIDS Trust continues legal battle over Truvada.
News EU approves Gilead's Truvada for HIV prevention But there are funding problems in UK, Australia and Canada.
News Merck, Pfizer and Gilead all interested in Medivation buy-ou... Sanofi has competition in its bid to acquire cancer specialist
News BridgeBio poised to challenge Pfizer after Attruby approval BridgeBio grabs FDA approval for its ATTR cardiomyopathy drug Attruby, setting up a challenge to market leader Pfizer
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
